2-weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial-Reference-Cited by-同舟云学术

2-weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial

Published:2013-02 Issue:2 Volume:14 Page:117-124
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Kellokumpu-Lehtinen Pirkko-Liisa,Harmenberg Ulrika,Joensuu Timo,McDermott Ray,Hervonen Petteri,Ginman Claes,Luukkaa Marjaana,Nyandoto Paul,Hemminki Akseli,Nilsson Sten,McCaffrey John,Asola Raija,Turpeenniemi-Hujanen Taina,Laestadius Fredrik,Tasmuth Tiina,Sandberg Katinka,Keane Maccon,Lehtinen Ilari,Luukkaala Tiina,Joensuu Heikki

Publisher

Elsevier BV

Subject

Oncology

Reference30 articles.

1. Prostate cancer;Damber;Lancet,2008

2. Chemotherapy-based treatment for castration-resistant prostate cancer;Seruga;J Clin Oncol,2011

3. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

4. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Pertylak;N Engl J Med,2004

5. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial;de Bono;Lancet,2010

Cited by 170 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting Treatment Effects from Surrogate Endpoints in Historical Trials in First-Line Metastatic Castration-Resistant Prostate Cancer;Clinical Genitourinary Cancer;2024-10

2. From biology to the clinic — exploring liver metastasis in prostate cancer;Nature Reviews Urology;2024-04-26

3. Contemporary Systemic Therapy Intensification for Prostate Cancer: A Review for General Practitioners in Oncology;Current Oncology;2024-02-15

4. Cost-Effectiveness Analysis of Systemic Therapy for Intensification of Treatment in Metastatic Hormone-Sensitive Prostate Cancer in India;Applied Health Economics and Health Policy;2024-01-10

5. Expanding Treatment Options for Older Adults With Prostate Cancer;JAMA Oncology;2023-12-01